硅酸铝镁在药剂学领域应用研究进展

谷士杰, 姚加

中国药学杂志 ›› 2017, Vol. 52 ›› Issue (4) : 263-266.

PDF(1085 KB)
PDF(1085 KB)
中国药学杂志 ›› 2017, Vol. 52 ›› Issue (4) : 263-266. DOI: 10.11669/cpj.2017.04.003
综述

硅酸铝镁在药剂学领域应用研究进展

  • 谷士杰1, 姚加2
作者信息 +

Advances in Research on Application of Magnesium Aluminumsilicatein Pharmaceutics

  • GU Shi-jie1, YAO Jia2
Author information +
文章历史 +

摘要

笔者通过从提高片剂的硬度;改善粉体的流动性和防止粉体吸潮结块的作用;油状药物的粉末化;将难溶性结晶药物与硅酸铝镁共同研磨,形成无定型产物,进而提高药物的溶出度;在固体分散制剂以及缓释制剂处方设计的应用等5个方面综述硅酸铝镁在药剂学应用研究的进展,并介绍硅酸铝镁理化特性和安全性评价结果。

Abstract

The research progress of the application of magnesium aluminum silicate in pharmaceutics was reviewed in this paper. We introduced the physiochemical properties and safety profile evaluations of magnesium aluminum silicate firstly. Then the research progress of the application of magnesium aluminum silicate was reviewed from the following five aspects: firstly, improving the fluidity of powder, increasing the hardness of tablets as well as preventingpowder from moisture caking; secondly, powdering oil-like drugs;thirdly, grinding poorly water-soluble crystalline drugs with magnesium aluminum silicate to form amorphous products, which can improve the dissolution rate of the drugs. In addition, the paper also reviewed the applications of magnesium aluminum silicate in solid dispersions, designing of sustained release formulations and so on.

关键词

硅酸铝镁 / 辅料 / 非晶态

Key words

magnesium aluminum silicate / pharmaceutical excipients / amorphous

引用本文

导出引用
谷士杰, 姚加. 硅酸铝镁在药剂学领域应用研究进展[J]. 中国药学杂志, 2017, 52(4): 263-266 https://doi.org/10.11669/cpj.2017.04.003
GU Shi-jie, YAO Jia. Advances in Research on Application of Magnesium Aluminumsilicatein Pharmaceutics[J]. Chinese Pharmaceutical Journal, 2017, 52(4): 263-266 https://doi.org/10.11669/cpj.2017.04.003
中图分类号: R944   

参考文献

[1] RABIEE S M, NAZPARVAR N, AZIZIAN M, et al. Effect of ion substitution on properties of bioactive glasses: a review [J]. Ceram Int, 2015, 41(6): 7241-7251.
[2] HWANG S J. Case study of pharmaceutical ingredients derived from clay minerals [J]. Economic Environ Geol, 2015, 48(3): 221-229.
[3] RONGTHONGA T, SUNGTHONGJEENB S, SIEPMANN J, et al. Quaternary polymethacrylate-magnesium aluminum silicate films: molecular interactions, mechanical properties and tackiness [J]. Int J Pharm, 2013, 458(1): 57-64.
[4] RONGTHONG T, SUNGTHONGJEEN S, SIEPMANN F, et al. Quaternarypolymethacrylate-magnesium aluminum silicatefilms:water uptake kinetics and film permeability [J]. Int J Pharm, 2015,490(1-2):165-172.
[5] LEA P, FRATINIB E, ITO K, et al. Dynamical behaviors of structural, constrained and free water in calcium- and magnesium-silicate-hydrate gels [J]. J Colloid Interface Sci, 2016, 469:157-163.
[6] SAKAI K, MASAYUKI M. Effects of magnesium alumino silicate administered to pregnant mice on pre-and post-natal development of offspings [J]. Pharmacometrics[応用薬理 (日)],1975,9:703-714.
[7] UENO N,SUZUKI H,OKABE S,et al. Effects of Meta-magnesium alumino silicate, extracts of licorice root and their combination on experimental ulcer and toxicity test [J]. Pharmacometrics[応用薬理 (日)], 1978,15:21-29.
[8] MANIRUZZAMANA M, NAIRB A, SCOOTARIS N, et al. One-step continuous extrusion process for the manufacturing of solid dispersions[J]. Int J Pharm, 2015,496(1):42-51.
[9] KALLAKUTA V R, BANDARI S,JUKANYI R, et al. Oral self-emulsifying powder of lercanidipine hydrochloride:formulation and evaluation [J]. Powder Technol, 2012, 221: 375-382.
[10] MACLEAN J, MEDINA C, DAURIO D, et al. Manufacture and performance evaluation of a stable amorphous complex of an acidic drug molecule and neusilin [J]. J Pharm Sci, 2011, 100(8): 3332-3344.
[11] BAHL D, HUDAK J, BOGNER R H. Comparison of the ability of various pharmaceutical silicates to amorphize and enhance dissolution of indomethacin upon co-grinding [J]. Parm Dev Tech, 2008, 13(3):255-269.
[12] VADHER A H,PARIKH J R,PARIKH R H, et al. Preparation and characterization of co-grinded mixtures of aceclofenac and neusilin US2 for dissolution enhancement of aceclofenac [J]. AAPS Pharm Sci Tech, 2009,10 (2): 606-614.
[13] KRUPA A, MAJDA D, JACHOWIC Z R, et al. Solid-state interaction of ibuprofen and neusilin US2[J]. Thermochim Acta, 2010,509: 12-17.
[14] MANISH K, GOLDMAN G D,BOGNER R H,et al. Enhanced drug dissolution and bulk properties of solid dispersions granulated with a surface adsorbent [J]. Pharm Dev Tech, 2001,6(4): 563-572.
[15] SANDER C, HOLML P. Porous magnesium aluminometasilicate tablets as carrier of a cyclosporine self-emulsifying formulation [J]. AAPS Pharm Sci Tech, 2009, 10 (4): 1388-1395.
[16] KARTHIK Y, JUKANTI J R,SUNKAVALLI S. In situ absorption and relative bioavailability studies of zaleplon loaded self-nanoemulsifying powders [J]. J Microencapsul, 2013, 30(2):161-172.
[17] MURA P, VALLERIM, CIRRILET M, et al. New solid self-microemulsifying systems to enhance dissolution rate of poorly water soluble drugs [J]. Pharm Dev Tech, 2012, 17 (3): 277-284.
[18] GURSOY R N,BENITA S. Self-emulsifying drug delivery systems (SEDDS)for improved oral delivery of lipophilic drugs [J]. Biomed Pharmacother, 2004, 58 (3): 173-182.
[19] AGARWAL V,SIDDIQUI A, ALI H, et al. Dissolution and powder flow characterization of solid self-emulsified drug delivery system (SEDDS) [J]. Int J Pharm, 2009, 366(1-2):44-52.
[20] BOLDHANE S P,KUCHEKER B S. Development and optimization of metoprolol succinate gastroretentive drug delivery system [J]. Acta Pharm, 2010, 60 (4):415-425.
[21] KHLIBSUWAN R, PONGJANYAKUL T. Spray-dried chitosan-magnesium aluminum silicate microparticles as matrix formers in controlled release tablets [J]. J Drug Deliv Sci Tec, 2015, 30:114-122.
[22] KANLANAKAWINKUL W, MEDLICOTT N J, RADES T, et al. Lysozyme-magnesium aluminum silicate microparticles:molecular interaction, bioactivity and release studies[J]. Int J Biol Macromol, 2015, 80: 651-658.
PDF(1085 KB)

Accesses

Citation

Detail

段落导航
相关文章

/